Sky Foundation, Inc. is dedicated to raising funds to advance research and increase awareness for the early detection and treatment of pancreas cancer
Enlighten → Engage → Encourage  

Goals For Improved Survival From Pancreas Cancer


A $50,000 grant from the foundation's research fund at the Karmanos Cancer Institute in Detroit, MI is awarded annually to a Karmanos scientist providing innovative pancreas cancer research

See More


Sky Foundation, Inc. awards an annual grant, up to $50,000, that focuses on early detection research for pancreas cancer

See More


The creation of a pancreas cancer database at Henry Ford Health System with the potential to outline the disparity in cancer care that will allow more novel and effective cancer treatment

See More

Rafael Fridman, Ph.D., Awarded $50,000 Grant from Sky Foundation, Inc., for Pancreatic Cancer Research

Wednesday, March 12, 2014
Courtesy: Karmanos Cancer Institute

Rafael Fridman, Ph.D., professor in the Department of Pathology at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, was awarded the Sky Foundation, Inc.’s first competitive scientific research grant of $50,000 for his innovative work in pancreatic cancer.

“It’s a privilege to award Dr. Fridman the Sky Foundation’s first $50,000 competitive scientific grant for his novel, collaborative approach to pancreatic cancer research,” said Sheila Sky Kasselman, pancreatic cancer survivor and founder of the Sky Foundation, Inc.

“Pancreatic cancer is one of the deadliest cancers, yet it continues to be radically underfunded. Our mission is to raise funds for research grants to help supplement government funding by providing direct support to scientists who offer new approaches in the prevention and early detection of pancreatic cancer. We believe Dr. Fridman’s work is worthy of this distinction.”

Read Full Article on Media Page

Funding For Pancreas Cancer

The graph below emphasizes the need for increased funding for pancreas cancer research. It is the least funded among the top five cancer killers. Only four percent of the NCI’s budget is allocated to pancreas cancer.

Graph: NCI budget 2012



Thursday, June 5 at 5:30 p.m.
Suburban Detroit home

Guest Speakers:

Diane M. Simeone, M.D.
Lazar J. Greenfield Endowed Professor of Surgery and Molecular and Integrative Physiology Director, Pancreatic Cancer Center, University of Michigan

Teri Brentnall, M.D.
Professor, Gastroenterology and Adjunct Professor, Pathology, University of Washington School of Medicine Founder and Director, Pancreas Cancer Surveillance Program, University of Washington Medical Center

Nancie Petrucelli, M.S., C.G.C.
Senior Genetic Counselor and Coordinator, Cancer Genetic Counseling Service, Karmanos Cancer Institute Clinical Assistant Professor, Department of Oncology and the Department of the Center for Molecular Medicine and Genetics, Wayne State University School of Medicine


Sunday, Nov. 2 at Noon
The Townsend Hotel
Birmingham, MI



33 Bloomfield Hills Parkway
Suite 275
Bloomfield Hills, Michigan 48304


501(c)3 Non-Profit Organization,
MICS 40147